New method reveals how cancerous tumors evolve and spread
March 14th, 2011 - 4:35 pm ICT by ANILondon, March 14 (ANI): A new method of analyzing cancerous tumors suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like bursts.
The finding has shed new light on the process of tumor growth and metastasis, and may help in the development of new methods to clinically evaluate tumors.
The new analytic method, devised by Cold Spring Harbor Laboratory (CSHL) Professor Michael Wigler and colleagues, features a process called single cell sequencing (SNS), which enables accurate quantification of genomic copy number within a single cell nucleus.
Genomic copy number refers to the amount of DNA in the nucleus. In cancer, portions of the genome are amplified or deleted, giving rise to extra or missing copies of key genes and interfering with mechanisms that normally control cell growth.
“We demonstrated that we can obtain accurate and high-resolution copy number profiles by sequencing a single cell from a cancerous tumor and that by examining multiple cells from the same cancer, we can make inferences about how the cancer evolved and spread,” said Wigler.
The CSHL team used two sampled tumors. Both were primary invasive breast cancer tumors of the so-called “triple-negative” type, generally regarded as the most aggressive form of breast cancer.
One tumor sample was known from prior testing to be polygenomic: composed of distinct populations of tumor cells, whose number, genomic type and evolutionary history were not readily measurable using conventional techniques.
The other sampled tumor was monogenomic: composed of cells of a single genetic type. Unlike the first sample, this one had metastasized, to the liver, and samples of that tumor were also subjected to analysis.
Using SNS, in concert with whole-genome amplification and next-generation sequencing, the CHSL team was able to show that in fact three distinct subpopulations of tumor cells were present.
It has been theorized that genetically heterogeneous tumor cell populations become mixed via gradual evolution. The CSHL team, in contrast, suggests the evolution is likely punctuated.
The second breast cancer sample analyzed by the team was of a single genomic type, but the team was able to determine that the liver metastasis to which it had given rise was very closely related, in genomic terms.
The study has been published in the journal Nature. (ANI)
- Personalized blood tests for cancer developed - Feb 19, 2010
- Full genetic blueprint of multiple prostate tumors unveiled - Feb 10, 2011
- Personalized cancer medicine now a step closer to reality - Apr 16, 2011
- Mouse genome offers human cancer clue - Mar 24, 2011
- Possible biomarker and therapeutic target for melanoma identified - Mar 18, 2011
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Genome code for most common form of pediatric brain cancer cracked - Dec 17, 2010
- 'Immune profile' may guide chemotherapy for breast cancer - Apr 04, 2011
- Gene linked to spread of eye melanoma identified - Nov 05, 2010
- Potential therapeutic target across a range of cancer types found - Oct 21, 2010
- Central switch that controls cell movements discovered - Dec 08, 2010
- Genetic pathways involved in breast cancer identified - Mar 04, 2011
- New potential target for breast cancer therapy identified - Dec 23, 2010
- Prostate and breast cancer usually recur in bone: Study - Mar 24, 2011
- Key component in the spread of lung cancer discovered - Mar 15, 2011
Tags: accurate quantification, analytic method, breast cancer, breast cancer tumors, cancerous tumor, cancerous tumors, cell nucleus, cold spring harbor, cold spring harbor laboratory, conventional techniques, cshl, distinct populations, invasive breast cancer, london march, resolution copy, spring harbor laboratory, tumor cells, tumor growth, whole genome amplification, wigler